Furthermore, a significant proportion of children harboring DYNC1H1 mutations present with MCD and drug-resistant epilepsy.[7] Thus, the search of the effective therapeutic strategies is necessary for patient with DYNC1H1-related epilepsy. This evidence concerns the gene DYNC1H1 and epilepsy.